Date published: 2025-12-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ciprofloxacin lactate (CAS 97867-33-9)

0.0(0)
Write a reviewAsk a question

Alternate Names:
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-Quinolinecarboxylic Acid Mono(2-hydroxypropanoate)
CAS Number:
97867-33-9
Molecular Weight:
421.42
Molecular Formula:
C20H24FN3O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Ciprofloxacin lactate, a lactate salt of the fluoroquinolone antibiotic ciprofloxacin, is extensively used in microbiological research to study bacterial DNA replication and cell division mechanisms. Its primary mode of action involves the inhibition of DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA transcription and replication. This specific inhibition results in supercoiling and eventual rupture of bacterial DNA, providing a detailed insight into the DNA damage response of bacteria under antibiotic stress. In research settings, ciprofloxacin lactate serves as a tool to investigate the molecular basis of bacterial resistance, particularly in pathogenic bacteria, by examining mutations that confer resistance to fluoroquinolones. This chemical is also pivotal in studies focusing on the cross-resistance mechanisms among different bacterial strains and the genetic pathways influencing these resistances. Furthermore, ciprofloxacin lactate is employed in synthetic biology and genetic engineering experiments to control microbial growth in genetic constructs, ensuring the selective propagation of genetically modified organisms. These applications make it a critical compound in the exploration of microbial ecology and the development of new bioengineering methodologies. It is also used to understand the environmental impact of antibiotics, studying how bacterial communities adapt and survive in various habitats, thereby contributing to broader ecological research.


Ciprofloxacin lactate (CAS 97867-33-9) References

  1. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.  |  Firsov, AA., et al. 1999. Antimicrob Agents Chemother. 43: 498-502. PMID: 10049257
  2. Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio.  |  Vostrov, SN., et al. 2000. Antimicrob Agents Chemother. 44: 879-84. PMID: 10722485
  3. Pharmacokinetics and toxicity of ciprofloxacin in adult horses.  |  Yamarik, TA., et al. 2010. J Vet Pharmacol Ther. 33: 587-94. PMID: 21062312
  4. Impact on resistance of the use of therapeutically equivalent generics: the case of ciprofloxacin.  |  Rodriguez, CA., et al. 2015. Antimicrob Agents Chemother. 59: 53-8. PMID: 25313208
  5. Preparation, degradation and in vitro release of ciprofloxacin-eluting ureteral stents for potential antibacterial application.  |  Ma, X., et al. 2016. Mater Sci Eng C Mater Biol Appl. 66: 92-99. PMID: 27207042
  6. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells.  |  Kucukoglu, V., et al. 2019. Int J Pharm. 569: 118578. PMID: 31362096
  7. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.  |  Tucker, DR. and Sieradzan, R. 1988. Am J Hosp Pharm. 45: 1910-1. PMID: 3228127
  8. Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatment with Polygonum capitatum Buch.-Ham. ex D. Don extracts.  |  Li, Z., et al. 2022. Front Pharmacol. 13: 1033667. PMID: 36386188
  9. Hydrogen bonded networks in hydrophilic channels: crystal structure of hydrated Ciprofloxacin Lactate and comparison with structurally similar compounds  |  M.D Prasanna a, T.N Guru Row a b. 2001. Journal of Molecular Structure. 559: 255-261.
  10. Removal of ciprofloxacin lactate by phosphoric acid activated biochar: Urgent consideration of new antibiotics for human health  |  Huating Jiang a b, Xiang Li a, Junning Bai a, Weiyu Pan a, Zhongyu Luo c, Yingjie Dai a. 2024. Chemical Engineering Science. 283.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Ciprofloxacin lactate, 100 mg

sc-278849
100 mg
$300.00